TAIEquity · Weekly research terminal

4746

Formosa Laboratories, Inc.

TW Healthcare Drug Manufacturers - Specialty & Generic

Latest week
7 Aug 2026
Weekly close
54.00 TWD
Fair value
74.51 TWD
Next-week expectancy
Undecided 47.37%
Weekly Report Chart Pack
Sharemaestro
Weekly Chart Pack Completed weekly market data · Independent research

TAI · Equity · Taiwan

4746

Formosa Laboratories, Inc.

Healthcare Drug Manufacturers - Specialty & Generic

Formosa Laboratories, Inc., together with its subsidiaries, engages in the manufacture and sale of active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally. It offers APIs in the areas of anticancer, vitamin D derivatives, anti-inflammatory and analgesic agents, immunomodulators, respiratory agents, cholesterol and phosphate binders, UV filter, iron deficiency anemia (IDA), CNS agents, MRI enhancing agents, steroids, antibiotics, and …

Last updated
7 Aug 2026
Exchange
Taiwan Stock Exchange · TAI
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
TWD
Market capitalisation
6,181,158,400
Fair value reference
74.51
Next-week expectancy
Undecided · 47.37%
Executive chart read

Over the latest 12 completed weeks ending 2026-08-07, 4746 rose 3.25%, moving from 52.30 to 54.00. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -33.97 and has improved across the 12-week window. Market Dynamics is 0.41 on the latest week. Next-week expectancy is undecided at 47.37% based on similar historical setup states.

Week Ending
7 Aug 2026
Latest Close
54.00
12-Week Change
3.25%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 47.37%
Signal Weeks
0 of 12

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
7 Aug 2026
Latest Close
54.00
12-Week Change
3.25%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 47.37%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-33.97
Market Dynamics
0.41

Over the latest 12 completed weeks ending 2026-08-07, 4746 rose 3.25%, moving from 52.30 to 54.00. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -33.97 and has improved across the 12-week window. Market Dynamics is 0.41 on the latest week. Next-week expectancy is undecided at 47.37% based on similar historical setup states.

Industry Peers

Taiwan equities in Drug Manufacturers - Specialty & Generic

Stock Exchange Week Open High Low Close Change
6446 PharmaEssentia Corporation TAI 7 Aug 2026 1100.00 1390.00 1090.00 1240.00 12.73%
4119 SCI Pharmtech, Inc. TAI 7 Aug 2026 47.20 51.60 47.00 51.60 9.32%
6472 Bora Pharmaceuticals Co., Ltd. TAI 7 Aug 2026 383.00 430.00 382.50 417.50 9.01%
1795 Lotus Pharmaceutical Co., Ltd. TAI 7 Aug 2026 175.00 192.00 174.50 188.00 7.43%
3054 LIWANLI Innovation Co., Ltd. TAI 7 Aug 2026 48.00 50.90 47.20 50.20 4.58%
1731 MAYWUFA CO TAI 7 Aug 2026 20.65 21.75 20.40 21.10 2.18%
1760 Panion & Bf Biotech Inc. TAI 7 Aug 2026 58.50 60.20 58.10 59.10 1.03%
1720 Standard Chemical & Pharmaceutical Co., Ltd. TAI 7 Aug 2026 56.80 57.30 55.80 57.00 0.35%
3705 YungShin Global Holding Corporation TAI 7 Aug 2026 53.60 53.80 52.80 53.50 -0.19%
1707 Grape King Bio Ltd TAI 7 Aug 2026 89.50 90.60 88.20 89.20 -0.34%
4108 PhytoHealth Corporation TAI 7 Aug 2026 11.20 11.45 11.00 11.15 -0.45%
1789 ScinoPharm Taiwan, Ltd. TAI 7 Aug 2026 19.25 19.50 18.30 18.90 -1.82%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.

Evidence context